FDA Approves First New Drug in 20 Years for Sickle Cell - NBC Boston
National & International News
The day’s top national and international news

FDA Approves First New Drug in 20 Years for Sickle Cell

In a study, the new drug, Endari, cut the number of pain crises and dangerous chest complications, and reduced hospitalizations and the need for transfusions

Find NBC Boston in your area

Channel 10 on most providers

Channel 60 and 8 Over the Air

    processing...

    NEWSLETTERS

    FDA Approves First New Drug in 20 Years for Sickle Cell
    ASSOCIATED PRESS
    In this March 7, 2007 file photo, a patient is given an injection for pain relief by a nurse at the Sickle Cell Center in Truman Medical Center, Wednesday, March 7, 2007 in Kansas City, Mo. Pain management is vital in the care of patients suffering from Sickle Cell disease.

    The U.S. Food and Drug Administration has approved the first drug in nearly 20 years for sickle cell, an inherited disease in which abnormally shaped red blood cells can't properly carry oxygen throughout the body, which can cause severe pain and organ damage.

    About 100,000 people in the U.S., mostly blacks, have the disorder and about 275,000 babies are born with it each year worldwide.

    In a study, the new drug, Endari, cut the number of pain crises and dangerous chest complications, and reduced hospitalizations and the need for transfusions.

    It is made by a California company, Emmaus Medical Inc., and approved for adults and children 5 and older.

    Olympians Share Their Most Embarrassing School Memories

    [NATL] Olympians Share Their Most Embarrassing School Memories

    From bad school pictures to awkward first day wardrobes, Team USA members can now look back on some of their most embarrassing school moments and laugh.

    (Published Friday, Aug. 18, 2017)